Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001193125-25-122435
Filing Date
2025-05-19
Accepted
2025-05-19 16:04:48
Documents
15

Document Format Files

Seq Description Document Type Size
1 DFAN14A d944178ddfan14a.htm DFAN14A 32699
2 GRAPHIC g944178txp10g1.jpg GRAPHIC 364832
3 GRAPHIC g944178txp11g1.jpg GRAPHIC 420991
4 GRAPHIC g944178txp12g1.jpg GRAPHIC 279395
5 GRAPHIC g944178txp13g1.jpg GRAPHIC 198261
6 GRAPHIC g944178txp14g1.jpg GRAPHIC 101556
7 GRAPHIC g944178txp1g1.jpg GRAPHIC 184700
8 GRAPHIC g944178txp2g1.jpg GRAPHIC 605466
9 GRAPHIC g944178txp3g1.jpg GRAPHIC 182640
10 GRAPHIC g944178txp4g1.jpg GRAPHIC 415224
11 GRAPHIC g944178txp5g1.jpg GRAPHIC 358795
12 GRAPHIC g944178txp6g1.jpg GRAPHIC 504334
13 GRAPHIC g944178txp7g1.jpg GRAPHIC 420292
14 GRAPHIC g944178txp8g1.jpg GRAPHIC 373839
15 GRAPHIC g944178txp9g1.jpg GRAPHIC 451899
  Complete submission text file 0001193125-25-122435.txt   6732236
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Subject) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-34207 | Film No.: 25963844
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 200 GREENWICH AVENUE 3RD FLOOR GREENWICH CT 06830
Business Address 200 GREENWICH AVENUE 3RD FLOOR GREENWICH CT 06830 2034090812
Deep Track Capital, LP (Filed by) CIK: 0001856083 (see all company filings)

EIN.: 853360885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A